Breast Cancer News
More Breast Cancer Information
This fact sheet educates patients on how to properly describe the details of their metastatic breast cancer pain to their oncologist.
This patient information fact sheet reviews how doctors use molecular profiling to offer patients more targeted therapy options.
This fact sheet provides information about the BRCA1 and BRCA2 genes and related genetic testing.
This fact sheet discusses evidence behind if antiperspirants and deodorants may be linked to breast cancer.
This fact sheet teaches patients how hormone therapy can help stop the growth of hormone-sensitive breast cancer tumors.
The treatment landscape in breast cancer has evolved dramatically within the past several decades.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Statistical Significance, Uncertainty, and KEYNOTE-010
- Chlorhexidine Dressing Reduces May Reduce Incidence of Catheter-related Bloodstream Infections
- Gene-expression Prognostic Signatures Guide Adjuvant Chemotherapy of Early-stage Breast Cancer
- PD-1 and Checkpoint Inhibitors May Benefit Some Patients With SCLC
- Carfilzomib Efficacious Against Multiple Myeloma Regardless of Cytogenetic Abnormalities
- Breast Cancer (Invasive) Treatment Regimens
- Breast Cancer (Recurrent or Metastatic) Treatment Regimens
- TRUS-biopsy Poorly Detects Prostate Cancer
- Model Predicts That Healthful Lifestyle Benefits Women at Risk of Breast Cancer
- Mental Disorder Risk High Among Patients With Cancer During Treatment and Before Diagnosis
- The Future of the Biomedical Research Workforce in the United States
- Dosage Adjustment to Increase Plasma Trough Levels Requires Investigation for Treatment of RCC and Sarcoma
- VSIG10L Gene May Signify Susceptibility to Esophageal Adenocarcinoma
- Researchers Identify the "Cell of Origin" in Basal Cell Carcinoma
- Half of Patients in Remission 11 Months After Nilotinib Discontinuation